<?xml version="1.0" encoding="UTF-8"?>
<p id="p0035">The objective of this review is to put forward the current scenario of the development and efficacy of nucleic acid-based therapeutics as potential anti-viral agents. Here, we have also summarized the potential benefits and challenges in the application of these anti-viral agents in the context of SARS-CoV-2 infection.</p>
